Windlas Biotech Limited — Board Meeting, 06-11-2025: Outcome of Board Meeting
06-11-2025 | 06:26 pm
06-11-2025 | 06:26 pm
Windlas Biotech's Board has approved the financial results for the quarter and half-year. Consolidated Q2 revenue reached ₹222.40 Cr with a profit of ₹17.80 Cr. Half-year revenue was ₹432.49 Cr, posting a profit of ₹35.46 Cr.
No comments yet. Be the first to comment!
